Back
NextCure, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
NXTC
NextCure, Inc.
Last Price:
$10.48
Seasonality Move:
-17.14%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NXTC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NextCure, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.26 | Buy |
| 20-day SMA: | 11.29 | Sell |
| 50-day SMA: | 11.88 | Sell |
| 200-day SMA: | 9.07 | Buy |
| 8-day EMA: | 10.51 | Buy |
| 20-day EMA: | 11.05 | Sell |
| 50-day EMA: | 11.62 | Sell |
| 200-day EMA: | 10.43 | Buy |
NextCure, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 44.27 | Sell |
| Chaikin Money Flow: | 10783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.3 - 12.78) | Sell |
| Bollinger Bands (100): | (10.48 - 13.36) | Sell |
NextCure, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NextCure, Inc. Stock
Is NextCure, Inc. Stock a Buy?
-
NextCure, Inc. share price is 10.72 while NXTC 8-day simple moving average is 10.26, which is a Buy signal.
-
The stock price of NXTC is 10.72 while NextCure, Inc. 20-day SMA is 11.29, which makes it a Sell.
-
NextCure, Inc. 50-day simple moving average is 11.88 while NXTC share price is 10.72, making it a Sell technically.
-
NXTC stock price is 10.72 and NextCure, Inc. 200-day simple moving average is 9.07, creating a Buy signal.
NXTC Technical Analysis vs Fundamental Analysis
Sell
47
NextCure, Inc. (NXTC)
is a Sell
Is NextCure, Inc. a Buy or a Sell?
-
NextCure, Inc. stock is rated a SellThe current NextCure, Inc. [NXTC] share price is $10.72. The Score for NXTC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
NextCure, Inc. Stock Info
Market Cap:
28.6M
Price in USD:
10.72
Share Volume:
10.8K
NextCure, Inc. 52-Week Range
52-Week High:
15.74
52-Week Low:
2.69
Sell
47
NextCure, Inc. (NXTC)
is a Sell
NextCure, Inc. Share Price Forecast
-
What is the NextCure, Inc. stock price today?The NextCure, Inc. stock price is 10.72 USD today.
-
Will NXTC stock go up or go down?NextCure, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is NextCure, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NextCure, Inc. is overvalued.
Is NextCure, Inc. Stock a Buy?
-
NextCure, Inc. share price is 10.72 while NXTC 8-day exponential moving average is 10.51, which is a Buy signal.
-
The stock price of NXTC is 10.72 while NextCure, Inc. 20-day EMA is 11.05, which makes it a Sell.
-
NextCure, Inc. 50-day exponential moving average is 11.62 while NXTC share price is 10.72, making it a Sell technically.
-
NXTC stock price is 10.72 and NextCure, Inc. 200-day simple moving average is 10.43, creating a Buy signal.
Fundamental Analysis of NextCure, Inc.
Is NextCure, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.91 per share, a decrease next quarter of $0.10 per share, an increase this year of $5.52 per share, and an increase next year of $1.90 per share.
Technical Analysis of NextCure, Inc.
Should I short NextCure, Inc. stock?
-
NXTC Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting NextCure, Inc. is a Sell
-
NextCure, Inc. Relative Strength Index (RSI) is 44.27, which suggest NextCure, Inc. is oversold
-
The Bollinger Bands (25) for NextCure, Inc. is (10.3 - 12.78), which suggest NextCure, Inc. is a Sell
-
The Bollinger Bands (100) for NextCure, Inc. is (10.48 - 13.36), which suggest NextCure, Inc. is a Sell
* NextCure, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.